Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines

Journal of Nutrition

Volumn 131, Issue 8, 2001, Pages 2197-2203

  Wolter, F ^a   Akoglu, B ^a   Clausnitzer, A ^a   Stein, J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Caco 2 cells; Cell cycle; Colon cancer; Resveratrol

Indexed keywords

CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN E; LEUCINE; RESVERATROL; THYMIDINE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PROTEIN EXPRESSION;

VIOLA (ANGIOSPERM);

EID: 0034900080     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/131.8.2197     Document Type: Article

References (47)

1. Resveratrol: A molecule whose time has come? And gone?
2. Biological effects of resveratrol
3. Occurrence of resveratrol in edible peanuts
4. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
5. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells
6. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells
7. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/ CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2
8. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells
9. Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells
10. Chemopreventive agent resveratrol, a natural product derived from grapes, reversibly inhibits progression through S and G2 phases of the cell cycle in U937 cells
11. Resveratrol causes arrest in the S-phase prior to fas-independent apoptosis in CEM-C7H2 acute leukemia cells
12. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
13. Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials
14. Resveratrol arrests the cell division cycle at S/G2 phase transition
15. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells
16. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression
17. Distinct roles for cyclin-dependent kinases in cell cycle control
18. Principles of CDK regulation
19. A genetic model for colorectal tumorigenesis
20. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
21. Enterocyte differentiation is compatible with SV40 large T expression and loss of p53 function in human colonic Caco-2 cells. Status of the pRb1 and pRb2 tumor suppressor gene products
22. Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation
23. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
24. Antiproliferative effects of natural human tumor necrosis factor-alpha, interferon-alpha, and interferon-gamma on human pancreatic carcinoma cell lines
25. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
26. Expression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate-induced cell differentiation
27. Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis
28. The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas
29. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells
30. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
31. Mammalian G1 cyclins
32. Rb function in cell-cycle regulation and apoptosis
33. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1
34. Inhibition of cyclin-dependent kinases by p21
35. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
36. Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis
37. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B
38. Correlation between DNA replication and expression of cyclins A and B1 in individual MOLT-4 cells
39. Resveratrol, a remarkable inhibitor of ribonucleotide reductase
40. DNA polymerase and topoisomerase II inhibitors from Psoralea corylifolia
41. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells
42. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure
43. Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21 (WAF1/ CIP1), and suppresses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2
44. Resveratrol causes arrest in the S-phase prior to fas-independent apoptosis in CEM-C7H2 acute leukemia cells
45. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway
46. Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine
47. Assessment of resveratrol bioavailability in the perfused small intestine of the rat